A Brazilian physical therapist has been leading a unique project in Rio de Janeiro since 2018, trying to help patients with ...

A Brazilian physical therapist has been leading a unique project in Rio de Janeiro since 2018, trying to help patients with ...

Corcept Therapeutics CORT announced that it has submitted a new drug application (NDA) to the FDA seeking approval for its lead pipeline candidate, relacorilant, for treating a new indication. The ...

The FDA already is scheduled to decide by Dec. 30 whether the same drug can be used by patients with hypercortisolism, also ...

As for those with hyperglycemia with or without hypertension at baseline, relacorilant significantly improved fasting glucose ...

Italian pharma major Recordati presented four poster presentations and one product theater featuring the company’s endocrinology portfolio at the Endocrine Society’s annual meeting, ENDO 2025, taking ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years. On June ...

Background: Cushing’s disease is a rare condition associated with a high cardiovascular risk and hypercortisolemia-related hemodynamic dysfunction, the extent of which can be assessed with a ...

Patients with Cushing's disease treated with bilateral adrenalectomy are also at risk for Nelson's syndrome (corticotroph tumor progression) which occurs in up to 50% of the patients. [1, 11, 19 ...

Cushing’s disease (a sub-type of Cushing’s syndrome) is cortisol elevated on the basis of pituitary overstimulation (ACTH, adrenocorticotropic hormone) of the adrenal glands.

Previously, the treatment had been indicated for Cushing disease, a subtype of Cushing syndrome.